The US Food and Drug Administration has approved a new therapy for type 1 diabetes in which people with the condition receive donor pancreatic cells capable of producing insulin
The US Food and Drug Administration has approved a new therapy for type 1 diabetes in which people with the condition receive donor pancreatic cells capable of producing insulin
Share this Article
Recommended